Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clinigma is a full-service Clinical Research Organization (CRO) headquartered in Cairo, Egypt, specializing in the Middle East and North Africa (MENA) region. The company provides comprehensive support for Phase I-IV clinical trials, including clinical operations, regulatory affairs, pharmacovigilance, and data management. Clinigma serves as a strategic partner for global pharmaceutical, biotechnology, and medical device companies seeking to leverage the diverse patient populations and evolving research infrastructure in the MENA markets. With a deep understanding of local regulatory requirements and a strong network of clinical sites, Clinigma facilitates efficient trial execution and high-quality data collection. The organization is dedicated to advancing clinical research standards in the region and ensuring compliance with international Good Clinical Practice (GCP) guidelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CLINIGMA.